In after-hours PTS trading, Astellas Pharma's trading price is ¥2,405 and trading volume is 100 shares. The previous day's closing price was ¥2,399, and trading conditions through the 24th are presented alongside earnings-related information.
According to Astellas Pharma's after-hours PTS data, the trading price was ¥2,405 (21:57), with trading volume at 100 shares. The opening, high and low prices were all around ¥2,405 as of 21:57, and trading was taking place outside regular market hours.
The article states that the previous day's closing price was ¥2,399, indicating a slight movement in the after-hours trading price compared with the previous day. The market data also includes changes from the TSE closing price and trading value.
For earnings-related information, the article includes a summary of Astellas Pharma's earnings report for the first quarter of the fiscal year ending March 2027. Revenue rose 26.7% year on year to ¥640.9 billion, operating profit increased by more than 93% to ¥184.5 billion, and quarterly profit attributable to owners of the parent rose 107.3% to ¥141.8 billion. The article also suggests that the full-year forecast may be revised upward.
Regarding future developments, the next earnings announcement is scheduled for around late October 2026. The article also presents analytical factors related to earnings stability and growth, identifying the penetration of key strategic products, foreign exchange trends and improvements in the cost structure as areas to watch.